These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2998977)

  • 21. CMV in kidney transplantation: a single center experience over 22 years.
    Nashan B; Lück R; Kliem V; Brunkhorst R; Schlitt HJ; Klempnauer J
    Clin Transpl; 1999; ():181-8. PubMed ID: 11038636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus infection after kidney transplantation using cyclosporin A and low-dose prednisolone immunosuppression.
    Mayer G; Watschinger B; Pohanka E; Graf H; Popow T; Ulrich W; Kovarik J
    Nephrol Dial Transplant; 1988; 3(4):464-8. PubMed ID: 2845305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L; Steinhoff J; Hartwig-Weber I; Bein G
    Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin.
    Condie RM; O'Reilly RJ
    Dev Biol Stand; 1982; 52():501-13. PubMed ID: 6299859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbid outcome of cytomegalovirus-negative transplant recipients receiving cytomegalovirus-positive kidneys.
    Weir MR; Irwin BC; Maters AW; Genemans G; Shen SY; Charache P; Williams GM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2137-41. PubMed ID: 3029915
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation.
    Basadonna G; Feria A; Perez R; Klein H; Sturges M; Colquhoun S
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):52-3. PubMed ID: 7940976
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of initial versus delayed cyclosporine therapy in cadaveric renal transplant patients.
    Lewis R; Hodge E; Novick A; Steinmuller D; Streem S; Cunningham R; Swift C; Goormastic M; Badhwar K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2088-92. PubMed ID: 3029914
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of cytomegalovirus infection after organ transplantation with passive immunization. An analysis of 6 randomized clinical trials.
    Metselaar H; Weimar W
    Beitr Infusionsther; 1992; 30():198-202. PubMed ID: 1284706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral prophylaxis in combined pancreas-kidney transplant recipients.
    Stratta RJ; Taylor RJ; Bynon JS; Lowell JA; Cattral MS; Frisbie K; Miller S; Radio SJ; Brennan DC
    Transplantation; 1994 Feb; 57(4):506-12. PubMed ID: 8116033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
    De Santo LS; Romano G; Mastroianni C; Roberta C; Della Corte A; Amarelli C; Maiello C; Giannolo B; Marra C; Ragone E; Grimaldi M; Utili R; Scardone M; Cotrufo M
    Transplant Proc; 2005; 37(6):2684-7. PubMed ID: 16182784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe kidney graft rejection in combined kidney and pancreas transplantation.
    Hedman L; Frisk B; Brynger H; Frödin L; Tufveson G; Wahlberg J
    Transplant Proc; 1987 Oct; 19(5):3911-2. PubMed ID: 3313961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
    Snydman DR; Werner BG; Heinze-Lacey B; Berardi VP; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS
    N Engl J Med; 1987 Oct; 317(17):1049-54. PubMed ID: 2821397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for the occurrence of pneumonia caused by cytomegaloviruses in patients with bone marrow transplants during prevention with cytomegalovirus hyperimmune globulin].
    Schmeiser T; Heit W
    Immun Infekt; 1985 Nov; 13(6):302-6. PubMed ID: 3000924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of cytomegalovirus infections in renal transplants].
    Rondeau E; Peraldi MN; Kanfer A; Sraer JD
    Nephrologie; 1991; 12(4):189-92. PubMed ID: 1660570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modification of the incidence and course of CMV infections following kidney transplantation by passive immunization--initial experiences with a hyperimmunoglobulin].
    Hoyer J; Dennin RH; Schulz E
    Immun Infekt; 1985 Nov; 13(6):285-9. PubMed ID: 3000921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year fate of 100 kidney transplants treated with low-dose cyclosporine without biopsy guidelines.
    Civati G; Del Favero E; Brando B; Broggi ML; Busnach G; Forti D; Belli L; Minetti L
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1856-7. PubMed ID: 3079051
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.
    Dreikorn K; Doerr HW; Geursen RG
    Scand J Urol Nephrol Suppl; 1985; 92():15-21. PubMed ID: 3008312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.